An analysis of PRMT5 and E2F1 expression suggests that the relationship, we have established has clinical relevance, as in diverse types of human cancer high level expression in tumour tissue was apparent, and within some cancers a further coincidence was apparent between the expression of PRMT5, E2F1 and cortactin/CTTN. The gene discussed is E2F1; the disease is neoplasm.